BioExtractions (Wales) Ltd.

BioExtractions (Wales) Ltd. is a UK-based firm focused on extracting high-value compounds for the pharmaceutical, agrochemical, chemical, and food sectors. The company employs advanced extraction techniques to provide tailored solutions for its clients. Founded in 2013 in Tredegar, UK, BioExtractions (Wales) Ltd.

specializes in the extraction of valuable compounds. The firm was acquired by Mercia Fund Managers in May 2014 for GBP 0. 4 million, marking a significant investment in its operations. The company was founded by Roger Jones, who has a history of involvement in the industry.

BioExtractions (Wales) Ltd. specializes in the extraction of high-value compounds from complex mixtures, catering primarily to the pharmaceutical, agrochemical, chemical, and food industries. The company's core services revolve around contract extraction utilizing advanced techniques such as High Performance Counter Current Chromatography (HPCCC), membrane filtration, and supercritical carbon dioxide extraction. These methodologies enable the isolation and purification of various compounds, ranging from natural products to synthetic molecules, tailored to meet specific client needs, whether in gram or kilogram quantities.

BioExtractions serves a diverse client base, including research institutions and commercial enterprises across Europe and beyond. The revenue generation model for BioExtractions (Wales) Ltd. is primarily built on contract services offered to B2B clients, including pharmaceutical and chemical manufacturers. Business transactions typically involve clients engaging BioExtractions for specific extraction projects, where the firm develops customized processes to meet client specifications.

The pricing structure is based on project scope, complexity, and the quantity of compounds extracted, with costs varying according to the technology employed and the required purity levels. The company’s offerings, including its flagship HPCCC services, support clients from early development phases to full-scale production, emphasizing tailored solutions that align with industry requirements. Following its acquisition in May 2014, BioExtractions (Wales) Ltd. plans to utilize the GBP 0.

4 million from the funding to enhance its extraction capabilities and expand its product offerings. The company aims to explore new markets in Asia and North America by 2025, capitalizing on its advanced extraction technologies to meet growing global demand. Investments will also focus on the development of new extraction methodologies to further enhance efficiency and effectiveness in compound isolation.